weight

WeightWatchers on the Brink: Bankruptcy Filing Looming

1 month ago

In a shocking turn of events that may reshape the landscape of weight-loss and wellness services, WeightWatchers is reportedly preparing to file for bankruptcy within the next few weeks. The company, known for its structured dieting programs and support systems, has struggled in recent years amid growing competition and changing consumer preferences.

Planet Fitness Ditches Cardio Equipment in Bold Shift to Weightlifting Focus

2 months ago

In a surprising move that could reshape the landscape of fitness culture, Planet Fitness has announced a significant shift in its gym equipment offerings. In an effort to streamline its focus and cater to evolving member preferences, the popular fitness chain plans to phase out its traditional cardiovascular equipment in favor of a robust selection of weightlifting machinery.

Lilly's New Weight-loss Pill Rivals Ozempic, Leading to Surge in Stock Prices

2 months ago

In a significant development within the pharmaceutical market, shares of Eli Lilly surged following the announcement of promising results for its new weight-loss medication, believed to be on par with the well-established Ozempic. This news has generated considerable enthusiasm amongst investors and healthcare professionals alike, with the potential to reshape the competitive landscape of weight-loss therapies.

Major Setback for Pfizer: Obesity Pill Development Halted Due to Liver Injury Concerns

2 months ago

In a significant development within the pharmaceutical sector, Pfizer Inc. has announced the abandonment of its obesity treatment pill, a decision driven by alarming reports of liver injuries associated with the medication. This setback marks a considerable shift in the company's strategy to target the growing obesity epidemic, which has seen a dramatic rise in global prevalence in recent years.

Hims Teams Up with Eli Lilly to Offer Zepbound Through Telehealth Services

2 months ago

In a significant development within the telehealth industry, Hims, a leading healthcare company focused on providing convenient access to prescription medications and wellness products, announced that it will begin selling Eli Lilly’s weight-loss drug, Zepbound, through its online platform. This strategic partnership marks a pivotal moment for both companies as they seek to expand their reach in the weight management market.

Roche Joins Forces with Zealand Pharma in a $5.3 Billion Deal to Combat Obesity

3 months ago

In a significant move within the pharmaceutical industry, Swiss giant Roche Holding AG has entered into a transformative agreement with Denmark's Zealand Pharma A/S, aimed at tackling the growing global epidemic of obesity. The partnership is valued at an impressive $5.3 billion, positioning both companies at the forefront of innovation in weight management therapeutics.

Weight Loss Medication Market Faces Disruption Amid Rising Competition

3 months ago

Recent developments in the weight loss medication market have sparked notable changes as emerging alternatives to popular drugs like Wegovy and Zepbound begin to surface. These new contenders are now exerting pressure on existing players, leading to a significant shift in dynamics within this rapidly evolving sector.

Novo Nordisk Launches Direct-to-Consumer Sales of Wegovy for Weight Loss

3 months ago

In a groundbreaking move in the pharmaceutical industry, Novo Nordisk has announced its decision to sell the popular weight-loss drug Wegovy directly to patients. This initiative marks a significant shift in how health-care products are delivered, potentially bypassing traditional pharmacy networks and providing patients with more immediate access to necessary medications for obesity management.

Glanbia Divests SlimFast Amid Shift Toward Weight Loss Medications

3 months ago

In a notable shift within the weight management market, Glanbia PLC, an international nutrition company, has announced its decision to divest its SlimFast brand. This strategic move comes in response to changing consumer preferences, particularly the increasing inclination towards prescription weight loss medications, which have gained popularity and significant traction in recent times.

Hims Exceeds 2025 Sales Projections Amid Weight Loss Product Concerns

3 months ago

In a surprising announcement, Hims and Hers Health Inc. has revealed its sales outlook for 2025, which exceeds many analysts' expectations despite facing uncertainty surrounding its weight loss product line. This update sent the company's stock soaring as investors reacted positively to the optimistic projections.